Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate Efficacy and Safety of oral intake of Naftopidil 75mg once daily for the improving clearance of ureteral or renal stones.
Full description
Prospective, Single-center, Double blind, Randomized controlled trial
Treatment
Follow up Assessments including X-ray(KUB), visual analogue pain scale, are done 2, 4, and 6 weeks after the ESWL.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
130 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Deok Hyun Han, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal